At what age is setmelanotide approved for use?

Setmelanotide is approved for use in individuals 6 years of age and older. This age range has been established based on clinical trials and safety data that demonstrate the medication's efficacy and safety in this population. The approval for this specific age group allows for effective intervention in addressing weight management issues associated with specific genetic conditions that cause obesity, such as pro-opiomelanocortin (POMC) deficiency, leptin receptor deficiency, and others.

By targeting a younger population starting from age 6, healthcare providers can help manage obesity at an earlier stage, potentially leading to improved health outcomes and a reduction in obesity-related complications in children. This age threshold reflects a combination of developmental considerations and the need for interventions to be early enough to make a meaningful impact on a child's health trajectory.